Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with coronary atherosclerotic heart disease and gastrointestinal disease undergoing percutaneous coronary intervention: study protocol for a non-inferiority randomized controlled trial.
Trials
; 24(1): 209, 2023 Mar 21.
Article
in En
| MEDLINE
| ID: mdl-36945020
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Coronary Artery Disease
/
Aspirin
/
Percutaneous Coronary Intervention
/
Rivaroxaban
/
Clopidogrel
/
Gastrointestinal Diseases
/
Myocardial Infarction
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Guideline
/
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Trials
Journal subject:
MEDICINA
/
TERAPEUTICA
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: